Genetic Analysis

Who Is Cedars-Sinai’s First Chief Genomics Officer?
Tech & Innovation Who Is Cedars-Sinai’s First Chief Genomics Officer?

In an era where healthcare is increasingly driven by personalized solutions, the announcement of a pioneering role at a major medical institution captures attention as a sign of transformative progress in the field of medicine. Genomic medicine, which tailors treatments to an individual’s genetic

Can Genetic Tests Predict Weight-Loss Drug Success?
Tech & Innovation Can Genetic Tests Predict Weight-Loss Drug Success?

What if a simple blood test could reveal the exact weight-loss drug that works best for an individual, cutting through years of frustrating trial and error, and offering hope in a world where obesity affects over 650 million adults? The struggle to find effective treatment is real and deeply

AACR 2025 Report Highlights Cancer Research Breakthroughs
Research & Development AACR 2025 Report Highlights Cancer Research Breakthroughs

Imagine a world where a cancer diagnosis no longer carries the weight of despair, but instead offers a pathway to tailored, effective treatment. In 2025, this vision is closer than ever, as groundbreaking advancements in cancer research reshape how the disease is prevented, detected, and treated.

Bipartisan Backing Boosts Vaccine Industry Confidence
Research & Development Bipartisan Backing Boosts Vaccine Industry Confidence

The vaccine industry in the United States finds itself at a critical juncture, where an unprecedented level of bipartisan support offers a glimmer of hope amid swirling controversies, technological debates, and regulatory uncertainties that could shape its future trajectory. A recent poll conducted

Should Hepatitis B Vaccine for Newborns Be Delayed?
Research & Development Should Hepatitis B Vaccine for Newborns Be Delayed?

What if a single policy change could jeopardize decades of progress in safeguarding children from a silent, deadly virus, and what would be the consequences of such a shift? The debate over delaying the hepatitis B vaccine from birth to age 4 has erupted into a heated controversy, pitting public

Is C1orf122 the Key to Hepatocellular Carcinoma Prognosis?
Research & Development Is C1orf122 the Key to Hepatocellular Carcinoma Prognosis?

Imagine a disease so pervasive that it ranks as the third leading cause of cancer-related deaths worldwide, with a staggering 90% of primary liver cancer cases falling under its umbrella. Hepatocellular carcinoma (HCC) presents an immense challenge to global health systems, with rising incidence

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later